Real-life effects of benralizumab on airway oscillometry in severe eosinophilic asthma

INTRODUCTION: Eosinophil depletion with benralizumab reduces exacerbations and improves disease control and FEV(1) in patients with severe eosinophilic asthma. However, few studies have investigated the effect of biologics on small airways dysfunction (SAD) even though the latter correlates better w...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Rory, Lipworth, Brian J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Asthma
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201257/
https://www.ncbi.nlm.nih.gov/pubmed/37208039
http://dx.doi.org/10.1136/bmjresp-2022-001472

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201257/
https://www.ncbi.nlm.nih.gov/pubmed/37208039
http://dx.doi.org/10.1136/bmjresp-2022-001472

Ejemplares similares